Amended and Restated Change in Control and Severance Benefit Plan Participation Agreement Tier 2 (EVP)Gw Pharmaceuticals PLC • February 26th, 2021 • Pharmaceutical preparations
GW UK CHANGE IN CONTROL AND SEVERANCE BENEFIT PLAN (GW PHARMA LIMITED / GW RESEARCH LIMITED)Gw Pharmaceuticals PLC • February 26th, 2021 • Pharmaceutical preparations
Transition Incentive Bonus OpportunityGw Pharmaceuticals PLC • February 26th, 2021 • Pharmaceutical preparations
Reference is made to the Transition Agreement, dated as of February 3, 2021 (the “Transition Agreement”), by and among Jazz Pharmaceuticals UK Holdings Limited, Jazz Pharmaceuticals plc (“Jazz”) and GW Pharmaceuticals plc (the “Company”), pursuant to which the Company will be acquired by Jazz.
February 25, 2021 Justin GoverGw Pharmaceuticals PLC • February 26th, 2021 • Pharmaceutical preparations
Greenwich Biosciences, Inc. (the “Company”) is pleased to offer you continued employment on the terms and conditions set forth in this offer letter agreement (the “Agreement”), effective as of the date it is signed by you and returned to the Company (the “Effective Date”). As of the Effective Date, this Agreement supersedes and replaces your offer letter of employment with the Company (formerly known as GW Pharmaceuticals Inc.) dated July 17, 2015, your service agreement with GW Research Limited dated February 26, 2013, as novated to GW Pharmaceuticals plc by means of transfer letter dated July 20, 2015, and any other offer letter or employment agreement or other employment arrangement between you and the Company or GW Pharmaceuticals plc (collectively, the “Prior Agreements”) and that as of the Effective Date any compensation and benefits under such Prior Agreements are hereby extinguished and replaced with the compensation and benefits under this Agreement.
Private & ConfidentialGw Pharmaceuticals PLC • February 26th, 2021 • Pharmaceutical preparations • England and Wales
You agree that this letter is a contract for services, and not a contract of employment. Your employment is governed by the terms of the amended and restated employment agreement with the Company’s wholly-owned subsidiary, Greenwich Biosciences, Inc., effective as of February 25, 2021 (the “Employment Agreement”).
GW UK CHANGE IN CONTROL AND SEVERANCE BENEFIT PLAN GW RESEARCH LIMITEDGw Pharmaceuticals PLC • February 26th, 2021 • Pharmaceutical preparations
Transition Incentive Bonus OpportunityTransition Agreement • February 26th, 2021 • Gw Pharmaceuticals PLC • Pharmaceutical preparations
Reference is made to the Transition Agreement, dated as of February 3, 2021 (the “Transition Agreement”), by and among Jazz Pharmaceuticals UK Holdings Limited, Jazz Pharmaceuticals plc (“Jazz”) and GW Pharmaceuticals plc (the “Company”), pursuant to which the Company will be acquired by Jazz.
Amended and Restated Change in Control and Severance Benefit Plan Participation Agreement Tier 1Gw Pharmaceuticals PLC • February 26th, 2021 • Pharmaceutical preparations
